Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictors
Niccolò Gori(Università Cattolica del Sacro Cuore), Ketty Peris(Università Cattolica del Sacro Cuore), Maria Esposito(University of North Carolina at Chapel Hill), Eugenia Veronica Di Brizzi(University of Campania "Luigi Vanvitelli"), Lina Maria Magnanimi(University of L'Aquila), Claudia Paganini(University of Rome Tor Vergata), Maddalena Nicoletti(University of Campania "Luigi Vanvitelli"), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Marina Talamonti(NorthShore University HealthSystem), Marco Galluzzo(University of Rome Tor Vergata), Anna Balato(University of Campania "Luigi Vanvitelli"), Maria Concetta Fargnoli(University of L'Aquila), Andrea De Berardinis(University of L'Aquila), Cataldo Patruno(Magna Graecia University), Flaminia Antonelli(Università Cattolica del Sacro Cuore), Giuseppe Lauletta(University of Naples Federico II), Francesca di Vico(University of Naples Federico II), Elena Ippoliti(Università Cattolica del Sacro Cuore), Luca Bianchi(University of Rome Tor Vergata), Luisa Boeti(Agostino Gemelli University Polyclinic), Maddalena Napolitano(University of Molise)
Cited by 2
Related Papers
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment
|European Journal of Cancer|2020|324
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
|European Journal of Cancer|2022|320
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
|Multiple Sclerosis Journal|2015|298
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
|European Journal of Cancer|2022|287